Oral Anticoagulants Market – Preventing Stroke in Atrial Fibrillation
Market Overview The oral anticoagulants market is expanding as the prevalence of atrial fibrillation (AF) rises globally. Oral anticoagulants, including warfarin and direct oral anticoagulants (DOACs), are essential for preventing stroke in AF patients. The market is projected to grow through 2030, driven by the aging population, increasing AF diagnosis, and growing preference for DOACs over...
0 Comments 0 Shares 19 Views 0 Reviews